A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
London School of Hygiene and Tropical Medicine
ClinicalTrials.gov Identifier:
NCT00522860
First received: August 28, 2007
Last updated: January 11, 2012
Last verified: January 2012
  Purpose

Trachoma is the leading infectious cause of blindness worldwide. Recurrent infection by Chlamydia trachomatis causes in-turning of the eyelids / lashes (trichiasis), leading to corneal damage and blindness. The WHO recommends corrective eyelid surgery for trichiasis. Unfortunately, trichiasis frequently returns following surgery. The purpose of this study is to compare the outcome of surgery (at one and two years) for trichiasis using two currently used alternative suture types: non-absorbable (silk) and absorbable (vicryl). We, the researchers, hypothesise that the supportive presence of the absorbable suture for a longer period produces more stable wound healing, leading to a better outcome.


Condition Intervention Phase
Trachomatous Trichiasis
Trachoma
Procedure: Trichiasis surgery with absorbable sutures
Procedure: Trichiasis surgery with non-absorbable sutures
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomised Controlled Trial of Non-absorbable (Silk) Sutures Verses Absorbable (Vicryl) Sutures During the Surgical Treatment of Trachomatous Trichiasis

Further study details as provided by London School of Hygiene and Tropical Medicine:

Primary Outcome Measures:
  • Recurrent trichiasis [ Time Frame: One and two years ] [ Designated as safety issue: No ]
    Recurrent trichiasis, defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at one year.


Secondary Outcome Measures:
  • Entropion [ Time Frame: One and two years ] [ Designated as safety issue: No ]
  • Corneal opacity [ Time Frame: One and two years ] [ Designated as safety issue: No ]
  • Visual Acuity Change [ Time Frame: One and Two years ] [ Designated as safety issue: No ]
  • Conjunctivilisation of the lid margin grade [ Time Frame: One and two years ] [ Designated as safety issue: No ]
  • Repeat Trichiasis Surgery [ Time Frame: At any time during two years followup. ] [ Designated as safety issue: No ]

Enrollment: 1300
Study Start Date: March 2008
Study Completion Date: May 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Vicryl Suture
Vicryl sutures, 5/0, 3/8 curved cutting needle
Procedure: Trichiasis surgery with absorbable sutures
Posterior lamellar tarsal rotation. Vicryl sutures, 5/0, 3/8 curved needle, cutting. Three everting sutures.
Active Comparator: Silk Suture
Silk suture, 4/0, 3/8 curved cutting needle
Procedure: Trichiasis surgery with non-absorbable sutures
Posterior lamellar tarsal rotation. Silk sutures. 4/0. 3/8 curved cutting needle. Three sets of everting sutures.

  Hide Detailed Description

Detailed Description:

Primary outcome measure:

Recurrent trichiasis, defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at one year.

Justification of primary outcome:

The aim of surgery is a permanent solution for trichiasis. If a patient has eyelashes touching the eyeball or there is clinical evidence that they are epilating to prevent this or they have required repeat trichiasis surgery, surgery can be deemed a failure.

Analysis of primary outcome measure

Intention to treat analysis of risk factors for recurrence.

Primary analysis of primary outcome:

It is expected that the important baseline characteristics (those that are known to affect the risk of recurrence) will be balanced between the two arms by stratified (for operating surgeon) randomisation. If this is found to be the case, the outcome of the surgery in the two arms will be compared in an unadjusted logistic regression model for recurrent trichiasis at one year. If the arms are found to be substantially imbalanced with respect to, pre-operative severity, gender or age, an appropriately adjusted logistic regression model will be used.

Individuals will be considered to be recurrent trichiasis cases if they have developed recurrent trichiasis at anytime during the one year follow-up period.

Secondary analysis of primary outcome:

  1. Effect modification We will assess effect modification of the intervention on recurrence at one year with the following factors by including an interaction term with treatment arm in the logistic regression model.

    1. Operating surgeon
    2. Pre-operative severity
    3. Sex
    4. Age group
    5. Conjunctival (papillary) inflammation
    6. Surgical complications
  2. Analysis of risk factors for recurrence:

    A multivariate logistic regression model will be used to identify potential explanatory factors for recurrent trichiasis at one year, in addition to the randomised suture type allocation. Other factors which will be examined in a model of recurrent trichiasis will include

    1. pre-operative disease severity

      • trichiasis
      • entropion
      • corneal opacity
    2. surgeon
    3. infection status at baseline and follow up timepoints
    4. inflammation status at baseline and follow up timepoints
    5. whether epilation is being practised
    6. sex
    7. age
    8. geographic location of patient's home
    9. literacy
    10. body mass index
    11. eye dryness

      • symptoms
      • signs
  3. Impact of intervention on time-to-first-recurrence. Kaplan-Meier analysis will be used to plot the survival curves for both treatment arms up to the final visit at 2 years. Cox regression will be used to assess the impact of the intervention on time to first recurrence. The hazard ratio will be estimated with Cox regression, adjusting for substantial baseline imbalances if appropriate.
  4. Recurrence at two years Intention-to-treat analysis will be used to assess the impact of the intervention on failure at 2 years. Failure will be defined as one or more eyelashes touching the globe or evidence of epilation (lash stubs) on examination, or a history of repeat trichiasis surgery since the baseline surgery, at either one year and/or two year follow-up visits.

Secondary outcome measures

  1. Lashes touching the eyeball The effect of the intervention on the number of lashes touching at one, and two years, respectively, will be analysed using zero inflated Poisson regression (i.e. treating number of lashes as a continuous variable)
  2. Entropion grade The effect of the intervention on the degree of entropion will be analysed by ordered logistic regression
  3. Conjunctivilisation of the lid margin grade The effect of the intervention on the degree of conjunctivilisation will be analysed by ordered logistic regression
  4. Clinical evidence of epilation The effect of the intervention on clinical evidence of epilation will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of epilation.
  5. Repeat surgery The effect of the intervention on the proportion with repeat surgery will be assessed at one and two years respectively with logistic regression. In addition, Cox regression will be used to analyse time-to-first evidence of first repeat surgery.
  6. Recurrence (lashes touching the eyeball, clinical evidence of epilation, repeat surgery) + history of epilation A secondary definition of recurrence will incorporate self-reported history of epilation. The primary analyses will be repeated with this definition of recurrence.
  7. Corneal opacification (CO) (categorical variable)

    1. Descriptive measures of the baseline severity of CO
    2. Description of the change in CO between baseline and one and two year follow up time-points.
    3. Ordered logistic regression analysis for factors associated with change in CO at one year and two years, respectively, including to identify factors associated with it, such as suture type and inflammation.
  8. Visual acuity (VA) (categorical variable) The effect of the intervention on the visual acuity (logMAR score) at 12 and 24 months will be analysed by linear regression.
  9. Surgical complications

    Surgical complications other than recurrence, such as granuloma, incomplete lid closure, inflammation (secondary to either of the two sutures materials) and infection can occur. Descriptive statistics, with significance testing will be used to compare the rates of occurrence of all complications and individual complications at any time during the study period between the two arms of the study.

  10. Patient satisfaction

Patients are asked the following questions on the follow up questionnaires that indicate their satisfaction with the procedure:

  1. Do you think your vision is worse, the same or better than before your surgery?
  2. Do you have eye pain?
  3. If you have eye pain is it worse, the same or better than before the operation?
  4. Do your eyes water?
  5. Did you find the surgery painful?
  6. If the eyelashes have returned or will return would you seek further surgery?

The proportion answering 'yes' to each of these questions will be compared between the two arms of the trial.

Additionally the answers to questions (b) and (d) will be compared between baseline (pre-operative) and the answer given at each time point within each arm.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Major trichiasis: more than 5 lashes touching the eye

Exclusion Criteria:

  • Previous eyelid surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00522860

Locations
Ethiopia
Bahir Dar Regional Health Bureau
Bahir Dar, Amhara, Ethiopia
Sponsors and Collaborators
London School of Hygiene and Tropical Medicine
Investigators
Principal Investigator: Matthew J Burton, PhD FRCOphth London School of Hygiene and Tropical Medicine
  More Information

Additional Information:
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: London School of Hygiene and Tropical Medicine
ClinicalTrials.gov Identifier: NCT00522860     History of Changes
Other Study ID Numbers: 5025
Study First Received: August 28, 2007
Last Updated: January 11, 2012
Health Authority: United Kingdom: Research Ethics Committee
Ethiopia: Ethiopia Science and Technology Commission
United States: Institutional Review Board

Keywords provided by London School of Hygiene and Tropical Medicine:
Trichiasis
Trachoma
Surgery
Suture
Ethiopia

Additional relevant MeSH terms:
Trachoma
Trichiasis
Conjunctivitis, Bacterial
Eye Infections, Bacterial
Bacterial Infections
Chlamydia Infections
Chlamydiaceae Infections
Gram-Negative Bacterial Infections
Eye Infections
Infection
Conjunctivitis
Conjunctival Diseases
Eye Diseases
Corneal Diseases
Eyelid Diseases

ClinicalTrials.gov processed this record on May 21, 2013